Related Experiment Video
Updated: May 30, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Dexamethasone prophylaxis in pediatric open heart surgery is associated with increased blood long pentraxin PTX3:
Franco Lerzo1, Giuseppe Peri, Andrea Doni
1Division of Cardiovascular Surgery, G. Gaslini Institute, IRCCS, Largo G. Gaslini 5, 16148 Genoa, Italy.
Insights
Dexamethasone before heart surgery significantly increased PTX3 levels in children undergoing cardiopulmonary bypass. This suggests PTX3 may play a protective role in reducing inflammation and improving outcomes.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Inflammation and Immunology
Background:
- Glucocorticoids (dexamethasone) before cardiopulmonary bypass (CPB) may mitigate the systemic inflammatory response.
- Long pentraxin PTX3 is a novel inflammatory marker with potential protective cardiovascular roles.
Purpose of the Study:
- To investigate the effect of dexamethasone prophylaxis on PTX3 levels in pediatric patients undergoing CPB.
- To evaluate the relationship between dexamethasone, PTX3, and other inflammatory markers (CRP, IL-1RII) during pediatric cardiac surgery.
Main Methods:
- A study of 29 children undergoing open heart surgery with CPB.
- Fourteen children received dexamethasone prophylaxis, while 15 served as controls.
- Blood levels of PTX3, CRP, IL-1RII, fibrinogen, and PTT were measured at various time points.
Main Results:
- PTX3 levels significantly increased during CPB in both groups, but were higher in the dexamethasone group (+D).
- C-reactive protein (CRP) levels were significantly higher in the control group (-D) postoperatively.
- Fibrinogen and partial thromboplastin time (PTT) were also higher in the -D group on postoperative day 1.
Conclusions:
- Dexamethasone prophylaxis in pediatric CPB is associated with increased blood PTX3 levels.
- Elevated PTX3 may contribute to reduced inflammatory markers and improved clinical outcomes in these patients.
Abstract:
Glucocorticoid administration before cardiopulmonary bypass (CPB) can reduce the systemic inflammatory response and improve clinical outcome. Long pentraxin PTX3 is a novel inflammatory parameter that could play a protective cardiovascular role by regulating inflammation. Twenty-nine children undergoing open heart surgery were enrolled in the study. Fourteen received dexamethasone (1st dose 1.5 mg/Kg i.v. or i.m. the evening before surgery; 2nd dose 1.5 mg/kg i.v. before starting bypass) and fifteen children served as control. Blood PTX3, short pentraxin C-reactive protein (CRP), interleukin-1 receptor II (IL-1RII), fibrinogen and partial thromboplastin time (PTT) were assayed at different times. PTX3 levels significantly increased during CPB in dexamethasone-treated (+D) and dexamethasone-untreated (-D) subjects, but were significantly higher in +D than -D patients. CRP levels significantly increased both in +D and -D patients in the postoperative days, with values significantly higher in -D than +D patients. Fibrinogen and PTT values were significantly higher in -D than +D patients in the 1st postoperative day. IL-1RII plasma levels increased in the postoperative period in both groups. Dexamethasone prophylaxis in pediatric patients undergoing CPB for cardiac surgery is associated with a significant increase of blood PTX3 that could contribute to decreasing inflammatory parameters and improving patient clinical outcome.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pericarditis III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pulmonary Embolism III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Distribution